UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143 | -48.0% | 10,189 | -67.2% | 0.01% | -64.7% |
| Q4 2022 | $275 | -99.9% | 31,046 | -36.9% | 0.03% | -37.0% |
| Q3 2022 | $410,000 | +3.8% | 49,222 | +2.0% | 0.05% | -8.5% |
| Q2 2022 | $395,000 | -20.7% | 48,271 | -15.6% | 0.06% | -11.9% |
| Q1 2022 | $498,000 | +34.2% | 57,224 | +46.5% | 0.07% | +42.6% |
| Q4 2021 | $371,000 | +7.5% | 39,064 | +90.5% | 0.05% | +34.3% |
| Q3 2021 | $345,000 | -19.0% | 20,505 | -26.5% | 0.04% | -27.1% |
| Q2 2021 | $426,000 | -7.2% | 27,883 | +18.4% | 0.05% | -36.8% |
| Q1 2021 | $459,000 | +20.8% | 23,544 | +130.8% | 0.08% | +230.4% |
| Q4 2017 | $380,000 | +29.7% | 10,200 | +9.7% | 0.02% | +15.0% |
| Q3 2017 | $293,000 | – | 9,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |